Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.

Marrazzo JM, Rabe L, Kelly C, Richardson B, Deal C, Schwartz JL, Chirenje ZM, Piper J, Morrow RA, Hendrix CW, Marzinke MA, Hillier SL; VOICE Study Team.

J Infect Dis. 2019 May 24;219(12):1940-1947. doi: 10.1093/infdis/jiz045.

PMID:
30753642
2.

Peer Mentoring at the Uganda Cancer Institute: A Novel Model for Career Development of Clinician-Scientists in Resource-Limited Settings.

Phipps W, Kansiime R, Stevenson P, Orem J, Casper C, Morrow RA.

J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00134.

3.

Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.

Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.

BMC Infect Dis. 2017 May 19;17(1):355. doi: 10.1186/s12879-017-2454-1. No abstract available.

4.

Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.

Gantt S, Orem J, Krantz EM, Morrow RA, Selke S, Huang ML, Schiffer JT, Jerome KR, Nakaganda A, Wald A, Casper C, Corey L.

J Infect Dis. 2016 Jul 1;214(1):36-44. doi: 10.1093/infdis/jiw076. Epub 2016 Feb 24.

5.

Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.

Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Kosloff B, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.

BMC Infect Dis. 2015 Sep 30;15:398. doi: 10.1186/s12879-015-1130-6. Erratum in: BMC Infect Dis. 2017 May 19;17 (1):355.

6.

Comparative performance of the Uni-Gold™ HSV-2 Rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory.

Shevlin E, Morrow RA.

J Clin Virol. 2014 Nov;61(3):378-81. doi: 10.1016/j.jcv.2014.08.012. Epub 2014 Aug 27.

7.

Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.

Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM; Partners PrEP Study Team.

Ann Intern Med. 2014 Jul 1;161(1):11-9. doi: 10.7326/M13-2471. Erratum in: Ann Intern Med. 2016 Dec 6;165(11):832.

PMID:
24979446
8.

Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.

Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA, Karita E, Kapiga S, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2013 Nov 1;208(9):1366-74. doi: 10.1093/infdis/jit333. Epub 2013 Jul 30.

9.

HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.

Kim HN, Scott J, Cent A, Cook L, Morrow RA, Richardson B, Tapia K, Jerome KR, Lule G, John-Stewart G, Chung MH.

J Viral Hepat. 2011 Oct;18(10):e447-52. doi: 10.1111/j.1365-2893.2011.01466.x. Epub 2011 May 13.

10.

Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.

Mujugira A, Morrow RA, Celum C, Lingappa J, Delany-Moretlwe S, Fife KH, Heffron R, De Bruyn G, Homawoo B, Karita E, Mugo N, Vwalika B, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

Sex Transm Infect. 2011 Apr;87(3):238-41. doi: 10.1136/sti.2010.047415. Epub 2011 Feb 9.

11.

Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Lingappa J, Nakku-Joloba E, Magaret A, Friedrich D, Dragavon J, Kambugu F, Joloba M, Whalen C, Coombs R, Celum C, Morrow RA.

Int J STD AIDS. 2010 Sep;21(9):611-6. doi: 10.1258/ijsa.2009.008477.

12.

Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.

Biraro S, Mayaud P, Morrow RA, Grosskurth H, Weiss HA.

Sex Transm Dis. 2011 Feb;38(2):140-7. doi: 10.1097/OLQ.0b013e3181f0bafb. Review.

PMID:
20706175
13.

Performance of HSV-2 type specific serological tests in men in Kenya.

Ng'ayo MO, Friedrich D, Holmes KK, Bukusi E, Morrow RA.

J Virol Methods. 2010 Feb;163(2):276-81. doi: 10.1016/j.jviromet.2009.10.009. Epub 2009 Oct 23.

14.

Microbial antagonists of Escherichia coli O157:H7 on fresh-cut lettuce and spinach.

Johnston MA, Harrison MA, Morrow RA.

J Food Prot. 2009 Jul;72(7):1569-75.

PMID:
19681287
15.

Use of the systems approach to determine the fate of Escherichia coli O157:H7 on fresh lettuce and spinach.

Doering HJ, Harrison MA, Morrow RA, Hurst WC, Kerr WL.

J Food Prot. 2009 Jul;72(7):1560-8.

PMID:
19681286
16.

Herpes simplex virus type-2 seropositivity among ever married women in South and north Vietnam: a population-based study.

Le HV, Schoenbach VJ, Herrero R, Hoang Pham AT, Nguyen HT, Nguyen TT, Muñoz N, Franceschi S, Vaccarella S, Parkin MD, Snijders PJ, Morrow RA, Smith JS.

Sex Transm Dis. 2009 Oct;36(10):616-20. doi: 10.1097/OLQ.0b013e3181a8cde4.

17.

Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.

Smith JS, Bailey RC, Westreich DJ, Maclean I, Agot K, Ndinya-Achola JO, Hogrefe W, Morrow RA, Moses S.

Sex Transm Infect. 2009 Apr;85(2):92-6. doi: 10.1136/sti.2008.031815. Epub 2008 Oct 27.

18.

Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.

Ngo TD, Laeyendecker O, Morrow RA, Lai S, Quinn TC.

Clin Vaccine Immunol. 2008 Aug;15(8):1301-3. doi: 10.1128/CVI.00006-08. Epub 2008 May 28.

19.

Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Morrow RA, Serwadda D, Gray RH, Quinn TC.

Clin Vaccine Immunol. 2008 May;15(5):888-90. doi: 10.1128/CVI.00453-07. Epub 2008 Mar 5.

20.

Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study.

Patnaik P, Herrero R, Morrow RA, Munoz N, Bosch FX, Bayo S, El Gueddari B, Caceres E, Chichareon SB, Castellsague X, Meijer CJ, Snijders PJ, Smith JS.

Sex Transm Dis. 2007 Dec;34(12):1019-24.

PMID:
18080353
21.

Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.

Ngo TD, Laeyendecker O, La H, Hogrefe W, Morrow RA, Quinn TC.

Clin Vaccine Immunol. 2008 Feb;15(2):382-4. Epub 2007 Dec 12.

22.
23.

Seroprevalence of herpes simplex virus type 1 in children in the United States.

Xu F, Lee FK, Morrow RA, Sternberg MR, Luther KE, Dubin G, Markowitz LE.

J Pediatr. 2007 Oct;151(4):374-7. Epub 2007 Aug 10.

PMID:
17889072
24.

Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.

Ramos S, Lukefahr JL, Morrow RA, Stanberry LR, Rosenthal SL.

Pediatr Infect Dis J. 2006 Oct;25(10):902-5.

PMID:
17006285
25.

Human herpesvirus 8 infection among adolescents in the REACH cohort.

Casper C, Meier AS, Wald A, Morrow RA, Corey L, Moscicki AB.

Arch Pediatr Adolesc Med. 2006 Sep;160(9):937-42.

PMID:
16953017
26.

High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study.

Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C.

Am J Epidemiol. 2006 Oct 15;164(8):733-41. Epub 2006 Aug 8.

PMID:
16896053
27.

Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition.

Wald A, Krantz E, Selke S, Lairson E, Morrow RA, Zeh J.

J Infect Dis. 2006 Jul 1;194(1):42-52. Epub 2006 May 24.

PMID:
16741881
28.

HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.

Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C.

Sex Transm Infect. 2006 Jun;82(3):229-35.

29.

Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.

Ameli N, Bacchetti P, Morrow RA, Hessol NA, Wilkin T, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM.

AIDS. 2006 Apr 24;20(7):1051-8.

PMID:
16603858
30.

Incidence and prevalence of herpes simplex virus infections in adolescent women.

Fife KH, Fortenberry JD, Ofner S, Katz BP, Morrow RA, Orr DP.

Sex Transm Dis. 2006 Jul;33(7):441-4.

PMID:
16540882
31.

Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.

Englund JA, Boeckh M, Kuypers J, Nichols WG, Hackman RC, Morrow RA, Fredricks DN, Corey L.

Ann Intern Med. 2006 Mar 7;144(5):344-9.

PMID:
16520475
32.

Risk factors for herpes simplex virus transmission to pregnant women: a couples study.

Gardella C, Brown Z, Wald A, Selke S, Zeh J, Morrow RA, Corey L.

Am J Obstet Gynecol. 2005 Dec;193(6):1891-9.

PMID:
16325589
33.

The relationship between condom use and herpes simplex virus acquisition.

Wald A, Langenberg AG, Krantz E, Douglas JM Jr, Handsfield HH, DiCarlo RP, Adimora AA, Izu AE, Morrow RA, Corey L.

Ann Intern Med. 2005 Nov 15;143(10):707-13.

PMID:
16287791
34.

Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.

Morrow RA, Friedrich D, Meier A, Corey L.

BMC Infect Dis. 2005 Oct 14;5:84. Erratum in: BMC Infect Dis. 2007;7:11.

35.

Genital herpes complicating pregnancy.

Brown ZA, Gardella C, Wald A, Morrow RA, Corey L.

Obstet Gynecol. 2005 Oct;106(4):845-56. Review. Erratum in: Obstet Gynecol. 2006 Feb;107(2 Pt 1):428. Obstet Gynecol. 2007 Jan;109(1):207.

PMID:
16199646
36.
37.

Poor correlation between genital lesions and detection of herpes simplex virus in women in labor.

Gardella C, Brown ZA, Wald A, Morrow RA, Selke S, Krantz E, Corey L.

Obstet Gynecol. 2005 Aug;106(2):268-74. Erratum in: Obstet Gynecol. 2005 Oct;106(4):869.

PMID:
16055574
38.

A population-based study of primary human herpesvirus 6 infection.

Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, Rhoads MP, Nguy L, Bornemann R, Morrow RA, Corey L.

N Engl J Med. 2005 Feb 24;352(8):768-76.

39.

Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls.

Stanberry LR, Rosenthal SL, Mills L, Succop PA, Biro FM, Morrow RA, Bernstein DI.

Clin Infect Dis. 2004 Nov 15;39(10):1433-8. Epub 2004 Oct 25.

PMID:
15546077
40.

Development and use of a type-specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G.

Morrow RA, Friedrich D, Krantz E, Wald A.

Sex Transm Dis. 2004 Aug;31(8):508-15.

PMID:
15273585
41.

Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.

Chohan BH, Taylor H, Obrigewitch R, Lavreys L, Richardson BA, Mandaliya KN, Bwayo JJ, Kreiss JK, Morrow RA.

J Clin Virol. 2004 Jun;30(2):137-44.

PMID:
15125869
42.

HIV infection and human herpesvirus-8 oral shedding among men who have sex with men.

Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, Hawes SE, Critchlow CW, Morrow RA, Corey L, Kiviat N, Wald A.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):233-8.

PMID:
15076237
43.

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Laeyendecker O, Henson C, Gray RH, Nguyen RH, Horne BJ, Wawer MJ, Serwadda D, Kiwanuka N, Morrow RA, Hogrefe W, Quinn TC.

J Clin Microbiol. 2004 Apr;42(4):1794-6.

44.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group.

N Engl J Med. 2004 Jan 1;350(1):11-20.

45.
47.

Higher systemic arterial pressures are rarely associated with cerebral perfusion pressure deterioration in brain injury.

Chovanes GI, Richards RM, Morrow RA, Rhodes M.

Surg Neurol. 2003 Sep;60(3):184-91; discussion 191-2.

PMID:
12922025
48.

Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Mbopi-Kéou FX, Bélec L, Dalessio J, Legoff J, Grésenguet G, Mayaud P, Brown DW, Morrow RA.

Clin Diagn Lab Immunol. 2003 May;10(3):388-93.

49.

Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L.

JAMA. 2003 Jan 8;289(2):203-9.

PMID:
12517231
50.

Critical theory: critical methodology to disciplinary foundations in nursing.

Mill JE, Allen MN, Morrow RA.

Can J Nurs Res. 2001 Sep;33(2):109-27. Review.

PMID:
11928332

Supplemental Content

Loading ...
Support Center